Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Major breakthroughs in lung cancer adjuvant treatment: Looking beyond the horizon.
Passiglia F, Bertaglia V, Reale ML, Delcuratolo MD, Tabbò F, Olmetto E, Capelletto E, Bironzo P, Novello S. Passiglia F, et al. Among authors: delcuratolo md. Cancer Treat Rev. 2021 Dec;101:102308. doi: 10.1016/j.ctrv.2021.102308. Epub 2021 Oct 18. Cancer Treat Rev. 2021. PMID: 34757306 Review.
Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center Experience.
Persano I, Cani M, Del Rio B, Ferrari G, Garbo E, Parlagreco E, Pisano C, Cetoretta V, Delcuratolo MD, Turco F, Audisio A, Cecchi C, Leone G, Napoli VM, Bertaglia V, Bianco V, Capelletto E, D'Amiano C, Di Maio M, Gianetta M, Novello S, Passiglia F, Scagliotti GV, Bironzo P. Persano I, et al. Among authors: delcuratolo md. Biomedicines. 2023 Jan 9;11(1):165. doi: 10.3390/biomedicines11010165. Biomedicines. 2023. PMID: 36672673 Free PMC article.
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
Leonetti A, Perrone F, Puntoni M, Maglietta G, Bordi P, Bria E, Vita E, Gelsomino F, De Giglio A, Gelibter A, Siringo M, Mazzoni F, Caliman E, Genova C, Bertolini F, Guaitoli G, Passiglia F, Delcuratolo MD, Montrone M, Cerea G, Pasello G, Roca E, Belluomini L, Cecere FL, Guida A, Manzo A, Adamo V, Rastelli F, Bulotta A, Citarella F, Toschi L, Zoratto F, Cortinovis DL, Berardi R, Follador A, Carta A, Camerini A, Salerno F, Silva RR, Baldini E, Cortellini A, Brighenti M, Santoni M, Malorgio F, Caminiti C, Tiseo M. Leonetti A, et al. Among authors: delcuratolo md. Eur J Cancer. 2024 May;202:114006. doi: 10.1016/j.ejca.2024.114006. Epub 2024 Mar 11. Eur J Cancer. 2024. PMID: 38489861
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy.
Turco F, Tucci M, Delcuratolo MD, Di Stefano RF, Pisano C, Audisio A, Audisio M, Ungaro A, Ortega C, Di Maio M, Scagliotti GV, Buttigliero C. Turco F, et al. Among authors: delcuratolo md. Cancer Commun (Lond). 2022 Aug;42(8):683-688. doi: 10.1002/cac2.12340. Epub 2022 Jul 22. Cancer Commun (Lond). 2022. PMID: 35866986 Free PMC article. No abstract available.
Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis.
Farinea G, Calabrese M, Carfì F, Saporita I, Poletto S, Delcuratolo MD, Turco F, Audisio M, Di Stefano FR, Tucci M, Buttigliero C. Farinea G, et al. Among authors: delcuratolo md. Cells. 2024 Aug 22;13(16):1396. doi: 10.3390/cells13161396. Cells. 2024. PMID: 39195285 Free PMC article.
16 results